Detecting Peripheral Arterial Disease in Primary Care: A Population Based Study

Overview

Journal Korean J Fam Med

Specialty Public Health

Date 2019 May 14

PMID 31079441

Citations 1

Authors

Tolga Vural

Makbule Neslisah Tan

Mehtap Kartal

Azize Dilek Guldal

Affiliations

Soon will be listed here.

Abstract

Background: Peripheral arterial disease (PAD) can progress silently without any clinical symptoms. Ankle-brachial index (ABI) is the recommended method used in primary care. We aimed to determine the prevalence of PAD and its related risk factors in primary care.

Methods: In this cross-sectional study, 250 participants aged ≥45 years were recruited randomly from the registered patients of family health center in a district of Izmir, Turkey. Patients' demographic data, PAD symptoms, and PAD risk factors were obtained. The PAD group consisted of patients with ABI levels <0.9; the non-compressible artery (NCA) group consisted of patients with ABI levels >1.3.

Results: The prevalence of PAD was 17.6% (22.5% in women and 11.1% in men), while that of NCA was 15.2% (12.7% in women and 25.0% in men). About 27.3% and 54.5% of patients with PAD did not have claudication and problems with walking distance, respectively. Of the NCA patients, 15.8% had problems with walking distance and 39.5% had claudication. Regression analysis revealed two predictors of PAD (age ≥65 years: odds ratio [OR], 3.51; 95% confidence interval [CI], 1.65-7.47; claudication: OR, 3.41; 95% CI, 1.58-7.39) and three predictors of NCA (age <65 years: OR, 2.55; 95% CI, 1.01-6.45; male sex: OR, 2.40; 95% CI, 1.10-5.25; triglyceride [TG] >200 mg/dL: OR, 4.11; 95% CI, 1.58-10.67).

Conclusion: PAD had a prevalence of 17.6% and was associated with age ≥65 years and claudication. NCA had a prevalence of 15.2% and was associated with age <65 years, TG >200 mg/dL, and male sex.

Citing Articles

The Frequency of Primary Healthcare Contacts Preceding the Diagnosis of Lower-Extremity Arterial Disease: Do Women Consult General Practice Differently?.

Porras C, Teraa M, Bots M, de Boer A, Peters S, van Doorn S J Clin Med. 2022; 11(13).

PMID: 35806951 PMC: 9267865. DOI: 10.3390/jcm11133666.

References

Meijer W, Grobbee D, Hunink M, Hofman A, Hoes A . Determinants of peripheral arterial disease in the elderly: the Rotterdam study. Arch Intern Med. 2000; 160(19):2934-8. DOI: 10.1001/archinte.160.19.2934. View

Hooi J, Kester A, Stoffers H, Rinkens P, Knottnerus J, Van Ree J . Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. J Clin Epidemiol. 2004; 57(3):294-300. DOI: 10.1016/j.jclinepi.2003.09.003. View

Selvin E, Erlinger T . Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004; 110(6):738-43. DOI: 10.1161/01.CIR.0000137913.26087.F0. View

Zanati S, Mouraria G, Matsubara L, Giannini M, Matsubara B . Profile of cardiovascular risk factors and mortality in patients with symptomatic peripheral arterial disease. Clinics (Sao Paulo). 2009; 64(4):323-6. PMC: 2694468. DOI: 10.1590/s1807-59322009000400010. View

Xu D, Li J, Zou L, Xu Y, Hu D, Pagoto S . Sensitivity and specificity of the ankle--brachial index to diagnose peripheral artery disease: a structured review. Vasc Med. 2010; 15(5):361-9. DOI: 10.1177/1358863X10378376. View

MacDougall A, Tandon V, Wilson M, Wilson T . Oscillometric measurement of ankle-brachial index. Can J Cardiol. 2008; 24(1):49-51. PMC: 2631249. DOI: 10.1016/s0828-282x(08)70548-8. View

Makowsky M, McAlister F, Galbraith P, Southern D, Ghali W, Knudtson M . Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy. Am Heart J. 2008; 155(2):348-55. DOI: 10.1016/j.ahj.2007.09.005. View

Bozkurt A, Tasci I, Tabak O, Gumus M, Kaplan Y . Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis--CAREFUL study: a national, multi-center, cross-sectional observational study. BMC Cardiovasc Disord. 2011; 11:4. PMC: 3033857. DOI: 10.1186/1471-2261-11-4. View

Gerhard-Herman M, Gornik H, Barrett C, Barshes N, Corriere M, Drachman D . 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary. Vasc Med. 2017; 22(3):NP1-NP43. DOI: 10.1177/1358863X17701592. View

10.

Carbayo J, Divison J, Escribano J, Lopez-Abril J, Lopez de Coca E, Artigao L . Using ankle-brachial index to detect peripheral arterial disease: prevalence and associated risk factors in a random population sample. Nutr Metab Cardiovasc Dis. 2006; 17(1):41-9. DOI: 10.1016/j.numecd.2005.08.009. View

11.

Hittel N, Donnelly R . Treating peripheral arterial disease in patients with diabetes. Diabetes Obes Metab. 2002; 4 Suppl 2:S26-31. DOI: 10.1046/j.1463-1326.2002.0040s2s26.x. View

12.

Aboyans V, Ho E, Denenberg J, Ho L, Natarajan L, Criqui M . The association between elevated ankle systolic pressures and peripheral occlusive arterial disease in diabetic and nondiabetic subjects. J Vasc Surg. 2008; 48(5):1197-203. DOI: 10.1016/j.jvs.2008.06.005. View

13.

Jiwakanon S, Adler S, Mehrotra R . Change in ankle-brachial index over time and mortality in diabetics with proteinuria. Clin Nephrol. 2012; 78(5):335-45. PMC: 4407335. DOI: 10.5414/CN107463. View

14.

Murabito J, Evans J, Nieto K, Larson M, Levy D, Wilson P . Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002; 143(6):961-5. DOI: 10.1067/mhj.2002.122871. View

15.

Mohler 3rd E, Giri J . Management of peripheral arterial disease patients: comparing the ACC/AHA and TASC-II guidelines. Curr Med Res Opin. 2008; 24(9):2509-22. DOI: 10.1185/03007990802274379. View

16.

Meijer W, Hoes A, Rutgers D, Bots M, Hofman A, Grobbee D . Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol. 1998; 18(2):185-92. DOI: 10.1161/01.atv.18.2.185. View

17.

Bergiers S, Vaes B, Degryse J . To screen or not to screen for peripheral arterial disease in subjects aged 80 and over in primary health care: a cross-sectional analysis from the BELFRAIL study. BMC Fam Pract. 2011; 12:39. PMC: 3121584. DOI: 10.1186/1471-2296-12-39. View

18.

Keeling A, Naughton P, Khalidi K, Ayyoub A, Kelly C, Leahy A . Should incidental asymptomatic angiographic stenoses and occlusions be treated in patients with peripheral arterial disease?. J Vasc Interv Radiol. 2009; 20(9):1133-40. DOI: 10.1016/j.jvir.2009.05.035. View

19.

Lilly S, Qasim A, Mulvey C, Churchill T, Reilly M, Eraso L . Non-compressible arterial disease and the risk of coronary calcification in type-2 diabetes. Atherosclerosis. 2013; 230(1):17-22. DOI: 10.1016/j.atherosclerosis.2013.06.004. View

20.

Chi Y, Jaff M . Optimal risk factor modification and medical management of the patient with peripheral arterial disease. Catheter Cardiovasc Interv. 2008; 71(4):475-89. DOI: 10.1002/ccd.21401. View